The National Health Service (NHS) has announced that it has launched the largest clinical study in the world on the Galleri test, a blood test that can identify 50 types of cancer early, before symptoms appear. If the promising experimental results of the diagnostic test are confirmed, the fight against cancer will be revolutionized.
As shown by multiple studies, several experimental blood tests have been developed in recent years that “hunt” for biomarcatori of the cancer, identifying it before i appear symptoms. In simple terms, these are tools for the early diagnosis that they can revolutionize the fight to tumors; as it is widely known, in fact, first the neoplasia and the greater the chances of survival for patients, up to ten times more compared to those with cancer al fourth stage, as stated by the English National Health Service (NHS). Now one of the most promising and advanced of these blood tests, the Gallery test, will be tested right in UK, where the largest experiment in the world for the new diagnostic method will be carried out, capable of identifying the biological signature said i 50 different types of cancer before symptoms appear.
The study, called NHS-Galleri, aims to involve in the first part 140 thousand volunteers from eight specific areas of England. THE withdrawals they will be carried out by mobile clinics in shopping malls, parks and other public areas, in order to make them easily usable for all people who will be selected by the NHS. Right now he’s sending tens of thousands of letters to people aged between 50 and 77 years old who have not been diagnosed with cancer in the past three years; the risk of developing cancer is known to increase with age. After the first sampling, a second one will follow at twelve months and another at two years, in order to collect data and verify the validity of the Galleri test. Of course in case of positive outcome the patients will be invited to undergo more thorough screening for the ritual exams. If the exam proves its effectiveness – the first results will be made available in 2023 -, the NHS will involve a further million people for the next phase of the trial, scheduled between 2024 and 2025. The ultimate goal is to identify early beyond the 75 percent of cancers which are diagnosed annually in the UK. An early diagnosis guarantees targeted treatments less heavy (such as long cycles of chemotherapy), as well as a significant increase in the chances of survival.
“Early diagnosis can save lives and this revolutionary new test can detect cancers before symptoms even appear, giving people the best chance of beating the disease,” the Secretary of Health and Care said in a press release. social Sajid Javid. “Ensuring fewer people need treatment for late-stage cancer is vital to patient care and another example of the NHS innovation for greater efficiency, which will be crucial to reducing backlog,” added the politician. . “We need to study the Galleri test carefully to find out if it can significantly reduce the number of cancers diagnosed at a late stage. The test could be a game changer for early cancer detection and we are thrilled to lead this important research, ”said Dr Peter Sasieni, Director of Cancer Research UK & King’s College London Cancer Prevention Trials Unit and one of the principal coordinators of the Research. “Cancer screening can find cancers early, when they are most likely to be treated successfully, but not all types of screening work,” he added. Therefore, all that remains is to await the results of this very important study, which could have a revolutionary impact worldwide.